Related Experiment Video
Updated: Feb 19, 2026
Flow Cytometric Characterization of Murine B Cell Development
Published on: January 22, 2021
Flow Cytometry of B-Cell Neoplasms
Steven H Kroft1, Alexandra M Harrington1
1Department of Pathology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
Insights
Flow cytometry is crucial for diagnosing B-cell lymphoproliferative disorders by identifying abnormal B-cell populations. This method aids in differential diagnosis, prognosis, and treatment planning for these conditions.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Flow cytometric evaluation is a standard diagnostic tool for B-cell lymphoproliferative disorders.
- Accurate diagnosis relies on identifying neoplastic B-cell populations based on specific antigen expression patterns.
Purpose of the Study:
- To describe the immunophenotypes of common B-cell neoplasms.
- To emphasize the role of flow cytometry in differential diagnosis.
- To highlight prognostic and therapeutic implications of immunophenotypic findings.
Main Methods:
- Utilized flow cytometry to analyze B-cell populations.
- Focused on identifying light chain restriction or absence of expression.
- Evaluated aberrant antigen expression compared to normal B-cells.
Main Results:
- Detailed immunophenotypic profiles of common B-cell neoplasms were established.
- Distinguished neoplastic from normal B-cells based on aberrant antigen expression.
- Provided a basis for immunophenotypic differential diagnosis.
Conclusions:
- Flow cytometry is essential for diagnosing B-cell lymphoproliferative disorders.
- Immunophenotypic analysis guides differential diagnosis, prognosis, and treatment strategies.
- Understanding aberrant antigen expression is key to identifying neoplastic B-cells.
Abstract:
Flow cytometric evaluation is considered a standard ancillary study for the diagnosis of most B-cell lymphoproliferative disorders. Establishing a neoplastic B-cell population depends on identification of light chain restriction or lack of light chain expression in mature neoplasms and demonstration of aberrant antigen expression in both immature and mature neoplasms, as compared with normal counterparts. The immunophenotypes of the most common B-cell neoplasms are herein described, with an emphasis on their immunophenotypic differential diagnosis and prognostic and therapeutic implications.
